Lipocine (LPCN) News Today $3.28 -0.03 (-0.91%) Closing price 03/28/2025 04:00 PM EasternExtended Trading$3.42 +0.14 (+4.39%) As of 03/28/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Lipocine (NASDAQ:LPCN) Coverage Initiated at StockNews.comMarch 30 at 2:07 AM | americanbankingnews.comLipocine’s Phase III trial of LPCN 1154 to begin for postpartum depressionMarch 27 at 3:48 PM | finance.yahoo.comLipocine initiates Phase 3 trial for LPCN 1154March 27 at 10:48 AM | markets.businessinsider.comLipocine Announces Initiation of Outpatient Phase 3 Postpartum Depression Trial of LPCN 1154March 26, 2025 | prnewswire.comLipocine (NASDAQ:LPCN) Now Covered by StockNews.comMarch 24, 2025 | americanbankingnews.comLipocine (NASDAQ:LPCN) Shares Cross Below 200 Day Moving Average - What's Next?March 22, 2025 | americanbankingnews.comLIPOCINE Earnings Results: $LPCN Reports Quarterly EarningsMarch 15, 2025 | nasdaq.comLipocine Says FDA Recommends Removing Cardiovascular Risk Warning From Testosterone Product LabelsMarch 14, 2025 | nasdaq.comLipocine Announces Financial Results for the Full Year Ended December 31, 2024March 13, 2025 | prnewswire.comLipocine Inc.: Lipocine Announces FDA Labeling Changes for Testosterone ProductsMarch 12, 2025 | finanznachrichten.deLipocine Announces FDA Labeling Changes for Testosterone ProductsMarch 12, 2025 | prnewswire.comL’action LPCN atteint son plus bas niveau sur 52 semaines à 2,92$March 5, 2025 | fr.investing.comLPCN stock touches 52-week low at $3.15 amid market challengesFebruary 26, 2025 | investing.comL'action LPCN atteint son plus bas niveau sur 52 semaines à 3,15$February 24, 2025 | fr.investing.comLipocine planifie une étude de phase 3 pour son médicament contre la dépression post-partumFebruary 6, 2025 | fr.investing.comLipocine plans phase 3 study for postpartum depression drugFebruary 6, 2025 | msn.comLipocine Receives Updated Regulatory Guidance on LPCN 1154February 6, 2025 | prnewswire.comLipocine Inc. Common Stock (LPCN) Latest After Hours TradesFebruary 2, 2025 | nasdaq.comLa FDA accélère le traitement de la sarcopénie de LipocineDecember 17, 2024 | fr.investing.comLipocine Inc.: FDA Grants Fast Track Designation to Lipocine for LPCN 1148 as a Treatment for Sarcopenia in Patients with Decompensated CirrhosisDecember 17, 2024 | finanznachrichten.deLipocine's LPCN 1148 Gets Fast Track Status To Treat Sarcopenia In Decompensated Cirrhosis PatientsDecember 17, 2024 | markets.businessinsider.comFDA Grants Fast Track Designation to Lipocine for LPCN 1148 as a Treatment for Sarcopenia in Patients with Decompensated CirrhosisDecember 17, 2024 | prnewswire.comLipocine announces publication, discussion of LPCN 1148November 19, 2024 | markets.businessinsider.comLipocine Announces Publication and Discussion of LPCN 1148 Manuscript at The Liver Meeting 2024 Editor's Cut SessionNovember 18, 2024 | prnewswire.comLipocine Announces Financial Results for the Third Quarter Ended September 30, 2024November 7, 2024 | prnewswire.comLipocine conclut un accord pour commercialiser TLANDO en Corée du SudOctober 31, 2024 | fr.investing.comLipocine Announces Distribution and License Agreement with SPC Korea to Commercialize TLANDO® in South KoreaOctober 31, 2024 | prnewswire.comLipocine annonce des résultats prometteurs pour l'étude sur la brexanolone oraleOctober 12, 2024 | fr.investing.comLipocine Announces Positive Oral Brexanolone Quantitative EEG ResultsOctober 10, 2024 | prnewswire.comLipocine signs supply and distribution agreement with Pharmalink for TlandoOctober 10, 2024 | finance.yahoo.comLipocine Inks Distribution Deal With Pharmalink To Commercialize TLANDO In GCC CountriesOctober 8, 2024 | markets.businessinsider.comLipocine Announces Supply and Distribution Agreement with Pharmalink to Commercialize TLANDO® in the Gulf Cooperation Council (GCC) CountriesOctober 8, 2024 | prnewswire.comLipocine to Host Virtual KOL Event on LPCN 2401 for Improved Body Composition in Obesity Management on October 16, 2024October 2, 2024 | prnewswire.comLipocine to Present at H.C. Wainwright 8th Annual MASH Investor ConferenceSeptember 30, 2024 | prnewswire.comAlliance Global Partners Initiates Coverage of Lipocine (LPCN) with Buy RecommendationSeptember 26, 2024 | msn.comLipocine Announces Phase 2 Data on LPCN 2401 to be Presented at ObesityWeek®September 5, 2024 | prnewswire.comLipocine to Present at H.C. Wainwright 26th Annual Global Investment ConferenceAugust 27, 2024 | prnewswire.comLipocine Announces Financial Results for the Second Quarter Ended June 30, 2024August 8, 2024 | prnewswire.comPostpartum Depression Drugs Market Size Report 2034 | Pfizer, Sage Therapeutics, Lipocine Inc, Eli Lilly and Company, GSK, Canopie, TalkspaceAugust 2, 2024 | theglobeandmail.comLipocine Announces LPCN 1154 Meets Bioequivalence with IV Brexanolone in Pivotal StudyJune 25, 2024 | prnewswire.comLipocine Presents 52 Week Results from LPCN 1148 Phase 2 Study in Late Breaking Session at EASL Congress 2024June 10, 2024 | prnewswire.com7 Penny Biotech Stocks to Triple Your InvestmentMay 28, 2024 | investorplace.comLPCN Stock Earnings: Lipocine Beats EPS for Q1 2024May 9, 2024 | investorplace.comLipocine Announces Financial Results for the First Quarter Ended March 31, 2024May 9, 2024 | finance.yahoo.comLipocine Announces Late Breaking Oral Presentation of Data from the Phase 2 Study of LPCN 1148 at EASL Congress 2024May 8, 2024 | prnewswire.comLipocine Announces Completion of Dosing in Pivotal Study of Postpartum Depression Candidate, LPCN 1154May 1, 2024 | prnewswire.comLipocine hopes obesity drug could boost muscle mass in combo with GLP1-RAsApril 12, 2024 | msn.comLipocine Inc.: Lipocine Announces Positive LPCN 2401 Clinical Results Showing Improved Body Composition in Participants with ObesityApril 11, 2024 | finanznachrichten.deLipocine annonce les résultats positifs d'une étude sur le traitement de l'obésitéApril 11, 2024 | fr.investing.comLipocine Reports Positive Phase 2 Results For LPCN 2401 In Participants With ObesityApril 11, 2024 | markets.businessinsider.com Remove Ads Get Lipocine News Delivered to You Automatically Sign up to receive the latest news and ratings for LPCN and its competitors with MarketBeat's FREE daily newsletter. Email Address LPCN Media Mentions By Week LPCN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LPCN News Sentiment▼0.330.80▲Average Medical News Sentiment LPCN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LPCN Articles This Week▼61▲LPCN Articles Average Week Remove Ads Get Lipocine News Delivered to You Automatically Sign up to receive the latest news and ratings for LPCN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies JSPR News CLSD News PYRGF News IGMS News ABOS News PYXS News AVTE News GNTA News MNOV News CRBP News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LPCN) was last updated on 3/30/2025 by MarketBeat.com Staff From Our PartnersWall Street’s “AI Oracle” Reveals Next Big Tech PlayA tiny American tech company could be at the center of the next big AI breakthrough. Wall Street's "AI Orac...InvestorPlace | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredCrypto Genius: 12,000% in 12 months? [Here’s how]We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | SponsoredForget Trump’s Tariffs, This March Event Is BiggerWhile everyone is distracted by Trump’s tariffs and a potential trade war… There’s something much bigger ha...Brownstone Research | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredTermination: 18F (read immediately)Have you ever heard of the government's 18F program? It helped manage digital services across the governmen...Altimetry | SponsoredDoomed: These 50 Stocks Will Die Under Trump’s MAGA policies.Remember Kodak? Sears? Circuit City? They all failed to adapt to the changing times. Now, history is abo...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lipocine Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lipocine With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy LPCN Stock Free LPCN Stock Alerts